Drug lookup
Drug reference

lisdexamfetamine

Prodrug (converted to D-amphetamine) · ADHD Agent

Prodrug (converted to D-amphetamine)ADHD AgentATC N06BA12
CDSCO approvedATC N06BA12
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
not curated
Top interactionssee all 12
  • AmiodaroneSevereDatabaseDDInter
  • AmisulprideSevereDatabaseDDInter
  • AnagrelideSevereDatabaseDDInter
  • Arsenic TrioxideSevereDatabaseDDInter

Mechanism

Lisdexamfetamine is a therapeutically inactive prodrug that is converted primarily in the blood to lysine and D-amphetamine, the active component.

Indications

attention-deficit/hyperactivity disorder (ADHD)

Side effects

Common
decreased appetitedizzinessdry mouthfatigueheadacheinsomniairritabilitynasal congestionnasal pharyngitisupper respiratory infectionvomitingdecreased weight

Drug interactions

Amiodarone
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amisulpride
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Anagrelide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Arsenic Trioxide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Bedaquiline
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Bepridil
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Bupropion
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Cabozantinib
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Ceritinib
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Chloroquine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Cisapride
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Citalopram
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Related guidelines

Ask House about lisdexamfetamine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team